Healthcare >> CEO Interviews >> September 14, 2001

Keith Gates – Integrity Pharmaceutical Corporation

Keith Gates, CEO of Integrity Pharmaceutical Corporation, brings to the company over 30 years of pharmaceutical manufacturing and distribution experience, primarily in specialty markets. Most recently he served as Vice President and General Manager of ASD Specialty Healthcare, a pharmaceutical distribution company. During his tenure, ASD grew from a start-up to $1.2 billion in sales over four years. While at ASD, he served on the board of OpTx Corporation, an oncology software and services company. Prior to joining ASD he served as Vice President of Sales for Immunex Corporation, a biotechnology company. Additionally he served as director of Lederle Oncology, which, during his tenure grew from three employees to 72 employees and sales of $120 million. He has held numerous management positions at Lederle Laboratories. Mr. Gates has a Bachelor's of Science in Biology from Augustana College. Profile
TWST: Could we begin with a brief historical sketch of Integrity

Pharmaceutical Corporation, and then an overview of what the company is

doing right now?

Mr. Gates: Integrity was founded in